Full Text View
Tabular View
Contacts and Locations
No Study Results Posted
Related Studies
Exposure and Response Prevention (ERP) With Behavioral- Versus Cognitive Therapy Rationale in the Tratment of OCD
This study is currently recruiting participants.
Verified by Norwegian University of Science and Technology, July 2006
Sponsors and Collaborators: Norwegian University of Science and Technology
Norwegian Foundation for Health and Rehabilitation
Information provided by: Norwegian University of Science and Technology
ClinicalTrials.gov Identifier: NCT00184262
  Purpose

The purpose of the study is to determine wether exposure and response prevention (ERP) is better when patients are presented with a behavioral- versus cognitive therapy rationale in the tratment of OCD.


Condition Intervention
Obsessive-Compulsive Disorder
Behavioral: Exposure and response prevention (ERP)

MedlinePlus related topics: Obsessive-Compulsive Disorder
U.S. FDA Resources
Study Type: Interventional
Study Design: Prevention, Randomized, Single Blind, Active Control, Parallel Assignment, Safety/Efficacy Study
Official Title: Exposure and Response Prevention (ERP) With Behavioral- Versus Cognitive Therapy Rationale in the Tratment of OCD

Further study details as provided by Norwegian University of Science and Technology:

Primary Outcome Measures:
  • scores on Y-BOCS and SCID-I

Estimated Enrollment: 50
Study Start Date: January 2003
Estimated Study Completion Date: December 2006
Detailed Description:

The purpose of the study is to determine wether exposure and response prevention (ERP) is better when patients are presented with a behavioral- versus cognitive therapy rationale in the tratment of OCD.

It is a randomized controlled trial including patients with OCD. 50 patients will receive 15 ERP sessions in a 3 month periode.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Obsessive-compulsive disorder

Exclusion Criteria:

  • active thought disorder, uncontrolled bipolar disorder, mental retardation, organic mental disorder, initiation or change in medication three months prior to inclusion in the study
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00184262

Contacts
Contact: Bjarne Hansen, Psychologist +47 73864604 bjarne.hansen@ntnu.no

Locations
Norway, 3008 Lade
Norwegian University of Science and Technology, INM Recruiting
Trondheim, 3008 Lade, Norway, 7441 Trondheim
Contact: Bjarne Hansen, Psychologist     +47 73864604     bjarne.hansen@ntnu.no    
Principal Investigator: Bjarne Hansen, Psychologist            
Sponsors and Collaborators
Norwegian University of Science and Technology
Norwegian Foundation for Health and Rehabilitation
Investigators
Principal Investigator: K. Gunnar Götestam, PhD MD Norwegian University of Science and Technology
  More Information

No publications provided

Study ID Numbers: 4941.1
Study First Received: September 13, 2005
Last Updated: July 24, 2006
ClinicalTrials.gov Identifier: NCT00184262  
Health Authority: Norway: Norwegian Social Science Data Services

Study placed in the following topic categories:
Anxiety Disorders
Mental Disorders
Obsessive-Compulsive Disorder

ClinicalTrials.gov processed this record on February 11, 2009